Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Personalis, Inc.

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PSNL●NASDAQ
HealthcareMedical - Diagnostics & Research
$15.88
$0.03(0.19%)
U.S. Market opens in 3h 21m

Personalis, Inc. (PSNL)

Meyka AI Score

Z

Key Financials

Market Cap1.7B
P/E Ratio-14.62
EPS (TTM)$-1.09
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 Month$15.14
3 Months$20.99
1 Year Target$15.90

PSNL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Personalis, Inc. (NASDAQ: PSNL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Personalis, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PSNL on the NASDAQ shows an RSI of 47.70, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.90 for the NASDAQ listing.

Key metrics behind Personalis, Inc.'s NASDAQ-traded stock include a P/E ratio of -14.62 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PSNL on the NASDAQ.

Price Performance (NASDAQ: PSNL)

1-Day Change
0.19%
5-Day Change
0.76%
1-Month Change
-3.52%
3-Month Change
34.80%
6-Month Change
160.33%
Year-to-Date (YTD) Change
99.50%
1-Year Change
64.05%
3-Year Change
1472.28%
5-Year Change
-16.86%
All-Time (Max) Change
-44.26%

Contact Information

https://www.personalis.com
650 752 1300
6600 Dumbarton Circle, Fremont, CA, 94555

Company Facts

2,600 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions